Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 9;10(9):e0135199.
doi: 10.1371/journal.pone.0135199. eCollection 2015.

Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations

Affiliations

Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations

Hanaa Shafiek et al. PLoS One. .

Abstract

Background: The electronic nose (e-nose) detects volatile organic compounds (VOCs) in exhaled air. We hypothesized that the exhaled VOCs print is different in stable vs. exacerbated patients with chronic obstructive pulmonary disease (COPD), particularly if the latter is associated with airway bacterial infection, and that the e-nose can distinguish them.

Methods: Smell-prints of the bacteria most commonly involved in exacerbations of COPD (ECOPD) were identified in vitro. Subsequently, we tested our hypothesis in 93 patients with ECOPD, 19 of them with pneumonia, 50 with stable COPD and 30 healthy controls in a cross-sectional case-controlled study. Secondly, ECOPD patients were re-studied after 2 months if clinically stable. Exhaled air was collected within a Tedlar bag and processed by a Cynarose 320 e-nose. Breath-prints were analyzed by Linear Discriminant Analysis (LDA) with "One Out" technique and Sensor logic Relations (SLR). Sputum samples were collected for culture.

Results: ECOPD with evidence of infection were significantly distinguishable from non-infected ECOPD (p = 0.018), with better accuracy when ECOPD was associated to pneumonia. The same patients with ECOPD were significantly distinguishable from stable COPD during follow-up (p = 0.018), unless the patient was colonized. Additionally, breath-prints from COPD patients were significantly distinguished from healthy controls. Various bacteria species were identified in culture but the e-nose was unable to identify accurately the bacteria smell-print in infected patients.

Conclusion: E-nose can identify ECOPD, especially if associated with airway bacterial infection or pneumonia.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors declare that no competing interests exist related with the technology or therapy used in this manuscript.

Figures

Fig 1
Fig 1. Flow chart of the studied population at every visit.
Fig 2
Fig 2. Identification of bacteria in vitro. Experimental setting.
Fig 3
Fig 3. Two-dimensional principal component (PC) analysis plots: showing breath-prints discrimination between ECOPD versus ECOPD with pneumonia in case of infection (A) and absence of infection (B); ECOPD with infection versus ECOPD without infection (C); ECOPD versus ECOPD with pneumonia without infection (D).
Fig 4
Fig 4. Comparison between e-nose smell-prints among different species of bacteria.
The graphs shows two-dimensional principal component (PC) analysis plots showing smell-prints discrimination between 2 species of bacteria.

Similar articles

Cited by

References

    1. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002. October;57(10):847–52. - PMC - PubMed
    1. Spencer S, Jones PW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. 2003. July;58(7):589–93. - PMC - PubMed
    1. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987. February;106(2):196–204. - PubMed
    1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004. June;23(6):932–46. - PubMed
    1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013. February 15;187(4):347–65. 10.1164/rccm.201204-0596PP - DOI - PubMed

Publication types

MeSH terms

Substances